About us

50 years of experience brought together to lead the medical cannabis future.

Linneo Health is the partner of choice for the pharmaceutical industry. We produce EU-GMP (Good Manufacturing Practices) and GACP (Good Agricultural and Collection Practices) certified medical cannabis and derivatives, integrating in every step the most innovative processes.

Linneo Health is the partner of choice for the medical cannabis pharmaceutical industry.

The company is supported by 50 years of experience in the agricultural and industrial production of strictly regulated pharmaceutical products. Linneo Health brings together this expertise and experience to contribute to the development of the cannabis industry, ensuring the highest production standards. In this sense, since October 2016, we have the official authorisation to produce cannabis for medical purposes.

In order to accomplish our ambitious expansion plan, we currently have 40,000 m2 of land devoted to the production of cannabis dried flowers. In addition, we have the industrial capacity to process over 12,000 tonnes of biomass per year for the production of extracts and active ingredients derived from cannabis. These capabilities, added to our expertise, position Linneo Health as one of the market leaders and a clear reference in the industry.

Our story

October 2016

We received the positive resolution of the authorization for the cultivation of cannabis with medical and scientific purposes from the Spanish Agency for Medicines and Health Products (AEMPS).

December 2017

We began construction of our first greenhouse in Spain, perfect location for the production of medical cannabis thanks to its naturally favorable conditions.

March 2018

We imported the first strains to our greenhouse, triggering the beginning of our agricultural activity in medical cannabis.

We also kicked off with our R&D program for extracted products in our industrial facility.

December 2018

We harvested the first crop of medical cannabis dried flowers manufactured in our greenhouse.

January 2019

We started the construction of our second greenhouse, substantially increasing our agricultural capacity.

Simultaneously, we obtained the first products in our extraction site: full spectrum extracts and distillates

May 2019

We began the construction of an additional extraction unit, adapted to current market needs, which makes us faster, more competitive and flexible.

June 2019

Our first outdoor growing area was approved, significantly expanding our agricultural capacity and strengthening our robust business model.

September 2019

We received the Good Manufacturing Practices (GMP) quality certificate from the Spanish Agency for Medicines and Health Products (AEMPS). We are the first Spanish cannabis company to receive this certification, which is a milestone of extraordinary relevance in the sector and positions us as leaders in the medical cannabis landscape.

December 2019

Our cultivation area was awarded with the Good Agricultural and Collection Practices (GACP) certificate, which restates our cultivation process as the reference in the medical cannabis sector.